Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors

Xiaozhen Zhang; Mengyi Lao; Jian Xu; Yi Duan; Hanshen Yang; Muchun Li; Honggang Ying; Lihong He; Kang Sun; Chengxiang Guo; Wen Chen; Haitao Jiang; Xiaoyu Zhang; Xueli Bai; Tingbo Liang

doi:10.1136/jitc-2021-003982

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

PDF +
Supplementary
Material

Immunotherapy biomarkers

Original research

Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors

Main menu

Online download statistics by month:

Online download statistics by month:

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month:

Read the full text or download the PDF:

Log in using your username and password